
AIkido Pharma AIKI
Geschäftsbericht 2025
hinzugefügt 31.03.2026
AIkido Pharma DPO 2011-2026 | AIKI
DPO Jährlich AIkido Pharma
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.92 | 7.63 | - | - | - | - | - | - | - | - | - | - | 32.8 K | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 32.8 K | 1.92 | 11 K |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Alnylam Pharmaceuticals
ALNY
|
55 | $ 330.34 | 3.6 % | $ 43.3 B | ||
|
Evogene Ltd.
EVGN
|
62.6 | $ 0.79 | 1.22 % | $ 27.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Завод ДИОД
DIOD
|
30.3 | - | - | - | ||
|
Фармсинтез
LIFE
|
306 | - | - | - | ||
|
Aptorum Group Limited
APM
|
405 | $ 0.89 | -4.33 % | $ 4.85 M | ||
|
Teligent, Inc.
TLGT
|
59.2 | - | -13.85 % | $ 16.1 M | ||
|
AbbVie
ABBV
|
65.5 | $ 206.69 | -1.01 % | $ 366 B | ||
|
Aquestive Therapeutics
AQST
|
395 | $ 4.09 | -0.97 % | $ 437 M | ||
|
Viela Bio, Inc.
VIE
|
997 | - | - | $ 2.91 B | ||
|
Ardelyx
ARDX
|
163 | $ 5.97 | 0.51 % | $ 1.44 B | ||
|
Akebia Therapeutics
AKBA
|
168 | $ 1.32 | -4.35 % | $ 339 M |